ARCA biopharma Announces Fiscal Year 2017 Financial Results and Provides Corporate Update Posted on March 22, 2018 by ARCA IT - Press Release, Uncategorized ABIO - 2017 Financial Results and Business Update - FINAL
ARCA biopharma Reports Topline Phase 2B Results for GENETIC-AF Clinical Trial Posted on February 26, 2018 by ARCA IT - Press Release, Uncategorized GENETIC-AF Topline Data - FINAL
ARCA biopharma Announces Completion of GENETIC-AF Phase 2B Clinical Trial Posted on January 8, 2018 by ARCA IT - Press Release, Uncategorized GENETIC-AF Trial Completion - FINAL
ARCA biopharma Announces Issuance of European Patent for Treating Cardiovascular Diseases and Conditions With a New Chemical Entity Utilizing Genetic Targeting | Plans Genetically-Targeted Development of AB171 for Peripheral Arterial Disease and Heart Failure Posted on November 16, 2017 by ARCA IT - Press Release, Uncategorized AB171 Patents and Development Program - FINAL
ARCA BIOPHARMA ANNOUNCES THIRD QUARTER 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE Posted on November 9, 2017 by ARCA IT - Press Release, Uncategorized 2017 Q3 Financial Results and Business Update - FINAL
Sidoti & Co. Fall 2017 Conference Announcement Posted on September 21, 2017 by ARCA IT - Press Release, Uncategorized Sidoti 2017 conf annc - FINAL
ARCA biopharma Announces Completion of Enrollment for GENETIC-AF Phase 2B Clinical Trial Posted on August 16, 2017 by ARCA IT - Press Release, Uncategorized GENETIC-AF Enrollment Completion - FINAL
ARCA biopharma Announces GENETIC-AF Data and Safety Monitoring Board Recommendation to Complete Phase 2B GENETIC-AF Clinical Trial Based on Efficacy and Safety Data in Phase 2B Interim Analysis Posted on August 9, 2017 by ARCA IT - Press Release, Uncategorized P2B Interim Analysis - DSMB Rec - Phase 2B - FINAL
ARCA biopharma Announces Second Quarter 2017 Financial Results and Provides Business Update Posted on August 3, 2017 by ARCA IT - Press Release, Uncategorized 2017 Q2 Financial Results and Business Update - FINAL
ARCA BIOPHARMA ANNOUNCES DATABASE LOCK FOR GENETIC-AF PHASE 2B INTERIM EFFICACY ANALYSIS – DSMB RECOMMENDATION ANTICIPATED IN AUGUST 2017 Posted on June 20, 2017 by ARCA IT - Press Release, Uncategorized P2B Interim Analysis - Database Lock - FINAL